Frontlight ResearchEarly access
Trial site
Showa University Hospital
- 3running trials
- 4closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Metastatic breast cancer3 trials
- Asthma1 trial
- Atopic dermatitis (eczema)1 trial
- Gastric and oesophageal cancer1 trial
- Head and neck cancer1 trial
- IgA nephropathy1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 35 trials
- Phase 21 trial
- Status
- Completed4 trials
- Active, not recruiting3 trials
- Lead sponsor
- Seagen, a wholly owned subsidiary of Pfizer2 trials
- Adlai Nortye Biopharma Co., Ltd.1 trial
- Amgen1 trial
- Daiichi Sankyo1 trial
- Novartis Pharmaceuticals1 trial
- and 1 more
Running trials
Active, not recruiting
A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors
Active, not recruiting
A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer
Active, not recruiting
Closed trials
Completed
Completed
The BURAN Study of Buparlisib in Patients With Recurrent or Metastatic HNSCC
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026